Growth Stock Evaluator

🇦🇺 ASX 300Most undervalued → 🇺🇸 S&P 500Most undervalued → 🇮🇳 NIFTY 500Most undervalued → 🇰🇷 KOSPI 200Most undervalued → 🇯🇵 Nikkei 225Most undervalued → 🇪🇺 EuropeMost undervalued →

Browse selective stock DCF valuations (ASX, S&P 500, NIFTY) →

Tick ASX stock for Australian tickers (e.g. BHP, CBA). Leave unticked for US tickers (e.g. AAPL).

Using another market? Add a suffix to the ticker

About this tool

Buffett, Graham, and Dividend-based valuation models all assume a mature, cash-generative company. A high-growth, pre-profit company — typical of SaaS, biotech, or EV manufacturers — fails those frameworks by construction, regardless of how good the underlying business is.

Growth Stock Evaluator scores companies against growth-appropriate criteria (Rule of 40, revenue growth, gross margin, cash runway, margin trajectory, dilution) and values them with two independent models built for negative or thin cash flow: a multi-stage DCF that ramps operating margin to a target over time, and an EV/Sales multiple approach.

Further reading: How to Value a Growth Stock That Isn't Profitable Yet — a worked Rocket Lab (RKLB) example →

Not sure what a term means? See the Financial Terms Glossary →

Frequently asked questions

Why do Buffett/Graham-style scores fail growth companies?

Traditional value-investing frameworks assume positive earnings, a low P/E, and often a dividend. A pre-profit growth company fails all of those by construction regardless of how good the underlying business is — this tool uses different, growth-appropriate criteria instead.

What is the Rule of 40?

Revenue growth % plus free cash flow margin % — if the total is 40 or higher, the company's growth is considered to justify its cash burn. It is a widely used SaaS/software health check, not a KashVector invention.

How is the EV/Sales target multiple chosen?

It is pre-filled from a sector-median starting point that you can edit freely — it is reference data, not a recommendation, and KashVector does not suggest what multiple your target company deserves.

Is this tool free and private?

Yes. No sign-up, no tracking. Your inputs stay in your browser.

How do I know when the valuation method changes?

Every change to how we value stocks, from new industry models to rate updates and refinements, is listed with its date, the reason and who it affects on our Changelog.